Galapagos has never been a company to sit still for long, but—even by its own standards—the decision to split in two while waving goodbye to 40% of its employees and a long-standing Gilead Sciences partnership is a bold move.
https://www.fiercebiotech.com/biotech/galapagos-splits-two-laying-40-staff-and-ending-gilead-partnership